October 12, 2022

There is an association between the development/exacerbation of AA and SARS-CoV-2 infection. However, more studies are required to evaluate this association and contribute to improvement in the dermatological and psychological outcomes in patients with COVID-19. COVID-19 is a viral SARS-CoV-2 infection associated with several immune-related dermatological conditions. Alopecia areata (AA) is an autoimmune disease with...

A recent systematic review assessed different treatment modalities for pediatric Alopecia areata (AA). Topical corticosteroids are the first-line treatment of AA in children. Alopecia areata (AA) is an auto-immune disorder that involves non-scarring hair loss. AA has a slightly greater prevalence in the pediatric population than in adults. Approximately 80% of individuals with patchy limited...